-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VK-2809 in Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VK-2809 in Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VK-2809 in Fibrosis Drug Details: VK-2809 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – VK-0612 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VK-0612 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VK-0612 in Type 2 Diabetes Drug Details: VK-0612 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – VK-2809 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VK-2809 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VK-2809 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: VK-2809 is...
-
Thematic Analysis
NewSocial Media Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Gen Z favorite TikTok has grown very quickly over the last few years, reaching more than a billion users. However, there are signs that TikTok's growth has begun to plateau for the first time since its launch in 2016. It has also been caught in the US-China geopolitical tensions, with US lawmakers introducing legislation that would ban app stores from distributing TikTok unless ByteDance, its Chinese owner, divests control of the popular video-sharing platform. In the meantime, Instagram's push into...
-
Product Insights
VK 7 INC Mine
The VK 7 INC Mine is a coal mine in India. It is currently in operation. Empower your strategies with our VK 7 INC Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to...
-
Product Insights
Veliki Krivelj (VK) Mine
The Veliki Krivelj (VK) Mine is a copper mine in Serbia. It is currently in operation. Empower your strategies with our Veliki Krivelj (VK) Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to...
-
Product Insights
NewNet Present Value Model: Viking Therapeutics Inc’s VK-2809
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
NewNet Present Value Model: Viking Therapeutics Inc’s VK-2735
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VK-2735 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VK-2735 in Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VK-2735 in Obesity Drug Details: VK-2735 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VK-2735 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VK-2735 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VK-2735 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: VK-2735...